MicroRNAs in Preeclampsia.

Area of Science:

• Biochemistry
• Genetics
• Obstetrics

Background:

• Preeclampsia (PE) poses significant global health challenges, with limited understanding of its pathogenesis hindering effective treatment.
• Current therapies for PE are primarily symptomatic, and diagnostic/prognostic tools remain limited.
• MicroRNAs (miRNAs), small non-coding RNAs regulating cellular functions, have emerged as critical players in biological processes.

Purpose of the Study:

• To explore the role of microRNAs (miRNAs) in the pathogenesis of preeclampsia (PE).
• To investigate miRNAs as potential diagnostic biomarkers and therapeutic targets for PE.

Main Methods:

• Review of accumulated evidence on miRNA involvement in preeclampsia over the last decade.
• Analysis of studies identifying differentially expressed miRNAs in mild and severe PE.
• Examination of miRNA-targeted genes and affected cellular pathways.

Main Results:

• Differentially expressed miRNAs are characteristic of both mild and severe PE.
• miRNAs regulate key pathways involved in PE, including immune response, angiogenesis, and trophoblast function.
• Altered miRNA expression impacts fundamental aspects of placentation.

Conclusions:

• MicroRNAs are significantly implicated in the pathophysiology of preeclampsia.
• miRNAs represent promising diagnostic biomarkers for PE.
• miRNAs hold potential as future therapeutic targets for preeclampsia management.